Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 56, Issue 5, 1997, Pages 361-367

  Lora, M ^a   Morisset, S ^a   Menard H A ^a   Leduc, R ^a   De Brum Fernandes, A J ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; ISOENZYME; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; RECOMBINANT ENZYME; TENOXICAM;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL STRAIN COS1; CONTROLLED STUDY; DRUG SCREENING; DRUG SPECIFICITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE;

ANIMALIA; MAMMALIA;

EID: 0030998284     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90584-6     Document Type: Article

References (45)

1. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971; 231: 232-235.
2. O'Banion M. K., Sadowski H. B., Winn V., Young D. A. A serum and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991; 266: 23261-23267.
3. Kujubu D. A., Fletcher B. S., Varnum B. C., Lim R. W., Hershman H. R. TIS10, a phorbol esther tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266: 12866-12872.
4. Xie W., Chipman J. G., Robertson D. L., Erikson R. L., Simmons D. L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991; 88: 2692-2696.
5. Hla T., Neilson K. Human Cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992; 89: 7384-7388.
6. O'Banion M. K., Winn V. D., Young D. A. cDNA Cloning and Functional Activity of a Glucocorticoid-Regulated Inflammation Cyclooxygenase. Proc Natl Acad Sci USA 1992; 89: 4888-4892.
7. Hershman H. R. Characterization of a gene encoding a second prostaglandin synthase/cyclooxygenase (PGS/COX), whose message and protein are induced by mitogens and inhibited by glucocorticoids. The 8th International Conference on Prostaglandins and Related Compounds, Montreal, 1992: 79.
8. Raisz L. G., Voznesensky O. S., Alander C. B., Kawaguchi H., Pilbeam C. C. Auto-amplification of inducible prostaglandin synthase (cyclooxygenase) in osteoblastic MC3T3-E1 and PY1A cells. J Bone Min Res 1993; 8: S161.
9. Takahashi Y., Taketani Y., Endo T., Yamamoto S., Kumegawa M. Studies on the induction of cyclooxygenase isoenzymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduce pathway. Biochem Biophys Acta 1994; 13: 217-224.
10. Ristimaki A., Garfinkel S., Wessendorf J., Maciag T., Hla T. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 1994; 269: 11769-11775.
11. de Brum-Fernandes A. J., Laporte S., Heroux M., Lora, M., Patry C., Ménard H-A., Dumais R., Leduc R., Expression of prostaglandin endoperoxide synthase-1 and prostaglandin endoperoxide synthase-2 in human osteoblasts. Biochem Biophys Res Commun 1994; 164: 1358-1365.
12. Gilbert R. S., Reddy S. T., Kujubu D. A., Xie W., Luner S., Hershman H. R. Transforming growth factor beta 1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 cells and in murine embryo fibroblasts. J Cell Biol 1994; 159: 67-75.
13. Mitchell M. K., Silver R. M., Carlton D. et al. An interleukin-lβ-inducible cyclooxygenase in human amnion. The 8th International Conference on Prostaglandins and Related Compounds, Montreal, 1992; 78.
14. O'Banion M. K., Winn V. D., Young D. A. grIPGHS: a second cyclooxygenase gene responsive to glucocorticoids, growth factors, and cytokines. The 8th International Conference of Prostaglandins and Related Compounds, Montreal, 1992; 79.
15. Masferrer J. L., Zweifel B. S., Seibert K., Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990; 86: 1375-1379.
16. Crofford L. J., Wilder R. L., Ritmaski A. P., Hajime S., Remmers E. F., Epps H. R., Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J Clin Invest 1994; 93: 1095-1101.
17. Masferrer J. L., Zweifel B. S., Manning P. T. et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and non-ulcerogenic. Proc Natl Acad Sci USA 1994; 91: 3228-3232.
18. DeWitt D. L., El-Harith E. A., Kraemer S. A. et al. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem 1990; 265: 5192-5198.
19. Fletcher B. S., Kujubu D. A., Perrin D. M., Herschman H. R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem 1992; 267: 4338-4344.
20. Meade E. A., Smith W. L., DeWitt D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal antiinflammatory drugs. J Biol Chem 1993; 268: 6610-6614.
21. Funk C. D., Funk L. B., Kennedy M. E., Pong A. S., Fitzgerald G. A. Human platelet-erythroleukemia cell prostaglandin G/H synthase cDNA cloning, expression and gene chromosomal assignement. FASEB J 1991; 5: 2304-2312.
22. Yokoyama C., Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989; 165: 888-894.
23. Smith W. L Prostanoid biosynthesis and mechanism of action. Am J Physiol 1992; 263: F181-F191.
24. Picot S., Peyron F., Donadille A., Vuillez J. P., Barbe G., Ambroise-Thomas P. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism. Immunology 1993; 80: 127-133.
25. Shimokawa T., Smith W. L. Prostaglandin Endoperoxide Synthase - The Aspirin Acetylation Region. J Biol Chem 1992; 267: 12387-12392.
26. Laneuville O., Breuer D. K., DeWitt D. L., Hla T., Funk C. D., Smith W L. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by non-steroidal antiinflammatory drugs. J Pharmctcol Exp Ther 1994; 271: 927-934.
27. Xie W., Robertson D. L., Simmons D. L. Mitogen-inducible prostaglandin G/H synthase: a new target for non-steroidal antiinflammatory drugs. Drug Dev Res 1992; 25: 249-265.
28. 1 alpha. Prostaglandins 1978; 15: 383-397.
29. Cromlish W. A., Payette P., Gulp S. A., Quellet M., Percival M. D., Kennedy B. P. High level expression of active human cyclooxygenase-2 in insect cells. Arch Biochem Biophys 1994; 314: 193-199.
30. Appleby S. B., Ristimaki A., Neilson K., Narko K., Hla T. Structure of the human cyclo-oxygenase-2 gene. BiochemJ 1994; 302: 723-727.
31. Mitchell J. A., Akarasereenont P., Thiermermann C., Flower R. J., Vane J. R. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90: 11693-11697.
32. Rome L. H., Lands W. E. M. Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by antiinflammatory drugs. Proc Natl Acad Sci USA 1975; 72: 4863-4865.
33. Vane J. R., Botting R. M. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995; 44: 1-10.
34. Humes J. L., Winter C. A., Sadowski S. J., Kuehl F. A. Jr. Multiple sites on prostaglandin cyclooxygenase are determinants in the action of non-steroidal anti-inflammatory agents. Proc Natl Acad Sci USA 1981; 78: 2053-2056.
35. Lecomte M., Laneuville O., Ji C., DeWitt D. L., Smith W. L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 1994; 269: 13207-13215.
36. Mancini J. A., O'Neil G. P., Bayly C., Vickers P.J. Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis. FEBS Lett 1994; 342: 33-37.
37. Van der Ouderaa F.J., Buytenhek M., Nugteren D. H., Van Dorp D. A. Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid. Eur J Biochem 1980; 109: 1-8.
38. Mizuno K., Yamamoto S., Lands W. E. Effects of non-steroidal anti-inflammatory drugs on fatty acid cycloosygenase and prostaglandin hydroperoxidase activities. Prostaglandins 1982; 23: 743-757.
39. Engelhardt G. Meloxicam: A potent inhibitor of COX-2. Abstracts of 9th International Conference on Prostaglandins and related compounds, Florence, 1994; 82.
40. Nilsen O G., Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet 1994; 26: 16-43.
41. Insel P. A. Analgesic-antipyretics and anti-inflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout. In: Gilman A. G., Rail T. W., Nies A. S., and Taylor P. eds. The Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon, 1990: 638-674.
42. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Ottomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994; 47: 55-59.
43. Klein T., Nüsing R. M., Pfeischifter J., Ulrich V. Selective inhibition of cyclooxygenase-2. Biochem Pharmacol 1994; 48: 1605-1610.
44. Seibert K., Zhang Y., Leahy K. et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994; 91: 12013-12017.
45. Gonzalez J. P., Todd P. A., Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1987; 34: 289-310.